The Effects of Different Types of Exercise on Pulmonary Inflammation and Fibrosis in Mice with Type 2 Diabetes Mellitus

The Effects of Different Types of Exercise on Pulmonary Inflammation and Fibrosis in Mice with Type 2 Diabetes Mellitus

<b>Background:</b> Diabetic lung disease, characterized by inflammation and fibrosis, is an emerging chronic complication of type 2 diabetes mellitus (T2DM). However, systematic studies on the effects of exercise interventions remain limited. This study aimed to investigate the impact of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Haoyang Gao, Xiaotong Ma, Ze Wang, Danlin Zhu, Yifan Guo, Linlin Zhao, Weihua Xiao
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Series:	Cells
Subjects:	type 2 diabetes mellitus exercise diabetic lung disease pulmonary fibrosis pulmonary inflammation
Online Access:	https://www.mdpi.com/2073-4409/14/13/1026
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Regular aerobic exercise ameliorates radiation-induced pulmonary fibrosis: An animal study
by: Da Bin Ko, et al.
Published: (2025-07-01)

Exercise improves pulmonary fibrosis and neurological symptoms via S100A12 inhibition
by: Yan Sun, et al.
Published: (2025-06-01)

A case of pulmonary aspergillosis masquerading as pulmonary tuberculosis in a patient with type 2 diabetes mellitus
by: Sidharth Shankar Panigrahi, et al.
Published: (2024-04-01)

Diabetes mellitus increases the risk of post-COVID-19 pulmonary fibrosis: a meta-analysis of observational studies
by: Fen Tan, et al.
Published: (2025-08-01)

The Management of Pulmonary Fibrosis in COVID-19
by: Cleopas Martin Rumende, et al.
Published: (2021-07-01)

The processes of inflammation and fibrosis in patients with chronic obstructive pulmonary disease
by: T.A. Pertseva, et al.
Published: (2020-12-01)

Differential proteomics of interstitial fluid in lung tissue associated with the progression of pulmonary fibrosis in mice
by: Xi Lu, et al.
Published: (2025-04-01)

Composition and modification of the lung microbiome in patients with idiopathic pulmonary fibrosis
by: Victoria Maria Ruta, et al.
Published: (2020-10-01)

Biological and pharmacological roles of pyroptosis in pulmonary inflammation and fibrosis: recent advances and future directions
by: Ya Liu, et al.
Published: (2024-12-01)

Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with chronic lung disease and pulmonary hypertension
by: Shameek Gayen, et al.
Published: (2025-02-01)

Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis
by: Nesrin Ocal, et al.

Computed tomography in evaluating the development of different types of pulmonary fibrosis in patients with interstitial lung diseases
by: A. A. Speranskaya, et al.
Published: (2016-03-01)

Features of the combined flow of pulmonary tuberculosis and diabetes mellitus
by: A.S. Shalmin, et al.
Published: (2012-04-01)

Features of the simultaneous course of pulmonary aspergillosis and tuberculosis on the background of type 1 diabetes mellitus (clinical case)
by: O. M. Raznatovska, et al.
Published: (2022-10-01)

Prevalence of pulmonary arterial hypertension in post-tuberculosis lung fibrosis patients: A cross-sectional observational study
by: Rupak Chatterjee, et al.
Published: (2023-12-01)

Vitamin D Deficiency in Patients with Type 2 Diabetes Mellitus with and without Pulmonary Tuberculosis
by: Wahiduddin Wahiduddin, et al.
Published: (2024-11-01)

Molecular mechanisms of the development of atrial fibrillation in patients with type 2 diabetes mellitus: prognostic role of biomarkers of fibrosis and inflammation
by: V. A. Ionin, et al.
Published: (2022-11-01)

Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective study
by: A. Denis, et al.
Published: (2025-05-01)

Breaking new ground in pulmonary fibrosis: Targeting Pathways and Therapeutic Innovations
by: Swadip Mishra
Published: (2025-04-01)

Longitudinal changes in the 6-minute walk test and the Glittre-activities of daily living test in adults with cystic fibrosis
by: Vera Lucia Barros Abelenda, et al.
Published: (2025-01-01)

Rheumatoid arthritis presenting by combined pulmonary fibrosis and emphysema with clubbing and pulmonary hypertension: A rare case report
by: Reza Basiri, et al.
Published: (2024-11-01)

Prospects for the use of flavonoid substances in pulmonary fibrosis (review of experimental studies)
by: E. A. Gubareva, et al.
Published: (2024-12-01)

Chronic obstructive pulmonary disease and type 2 diabetes mellitus – diseases with cytokine imbalance
by: L. N. Sorokina, et al.
Published: (2024-10-01)

Integrins and pulmonary fibrosis: Pathogenic roles and therapeutic opportunities
by: Zhangyang Bi, et al.
Published: (2025-06-01)

Self-assembled vectors derived from Aster tataricus L.f. mitigate bleomycin-induced pulmonary fibrosis in mice
by: Yuan Meng, et al.
Published: (2025-06-01)

Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment
by: Cleopas Martin Rumende
Published: (2021-07-01)

Tetrathiomolybdate alleviates bleomycin-induced pulmonary fibrosis by reducing copper concentration and suppressing EMT
by: Yajun Wang, et al.
Published: (2025-05-01)

Interruption of intermittent hypoxia attenuates the severity of pulmonary fibrosis in male mice
by: Zakaria Maakoul, et al.
Published: (2025-05-01)

Frequency of imaging phenotypes of pulmonary interstitial fibrosis
by: Wallace T. Miller Jr, et al.
Published: (2025-05-01)

Antrodia cinnamomea extract alleviates bleomycin-induced pulmonary fibrosis in mice by inhibiting the mTOR pathway
by: Ying-Wei Lan, et al.
Published: (2024-12-01)

APPLICATIONS OF DIABETIC FOOT EXERCISE TO INCREASE FOOT SENSITIVITY IN ELDERLY WITH TYPE 2 DIABETES MELLITUS
by: Siti Aisah, et al.
Published: (2023-10-01)

Ambulatory Oxygen for Pulmonary Fibrosis (OxyPuF): a randomised controlled trial and acceptability study
by: Rachel L Adams, et al.
Published: (2025-07-01)

Comparison of the Effects of Nintedanib and Pirfenidone on Pulmonary Function Test Parameters and Radiological Findings in Patients with Idiopathic Pulmonary Fibrosis: A Real-Life Study
by: Olcay Aycicek, et al.
Published: (2025-02-01)

The Effects of Two Different Intensities of Concurrent Training on Pulmonary Function in Female Patients With Type II Diabetes
by: Amirhossein Haghighi, et al.
Published: (2025-07-01)

Association of tracheal diameter with respiratory function and fibrosis severity in idiopathic pulmonary fibrosis patients
by: Nevin Fazlıoğlu, et al.
Published: (2025-04-01)

Effects of Sildenafil and Vitamin E on Paraquat-Induced Pulmonary Fibrosis in Rats
by: Fouziyeh Siahpour, et al.
Published: (2024-12-01)

Disorders of gut microbiota and fecal–serum metabolic patterns are associated with pulmonary tuberculosis and pulmonary tuberculosis comorbid type 2 diabetes mellitus
by: Yunguang Wang, et al.
Published: (2025-08-01)

Cardiac protection of wogonin in mice with pulmonary fibrosis by regulating Sirt1/ γ-H2AX pathway
by: Libo Wang, et al.
Published: (2025-04-01)

The patient journey and burden of disease in progressive pulmonary fibrosis in Japan: a cross-sectional survey
by: Yuko Kaneko, et al.
Published: (2025-04-01)

High matrix stiffness promotes senescence of type II alveolar epithelial cells by lysosomal degradation of lamin A/C in pulmonary fibrosis
by: Junhui Ba, et al.
Published: (2025-04-01)